WELCOME TO Q-MED
|
Q-Med is a rapidly growing and profitable biotechnology/medical device company that primarily develops, manufactures, markets and sells medical implants. Most of the products are based on the company's patented technology, NASHA™, for the production of stabilized non-animal hyaluronic acid.
The company today has more than 700 co-workers in 20 countries, with approximately 500 at the company's head office and production facility in Uppsala.
Q-Med had sales of 1,318 MSEK during 2007. Q-Med AB is listed in the Mid Cap segment of the OMX Nordic Stock Exchange in Stockholm.
|
|
|
|
|
|
|
Q-Med invites analysts, investors and media to Capital Markets Day on May 8th.
|
 Program »
|
|
|
|
|
|
Annual General Meeting 2008
|
The Annual General Meeting of Q-Med AB was held on Tuesday April 29, 2008 on Q-Med’s premises at Fyrisvallsgatan 5, Uppsala.
|
|
|
|
|
|
|
|
QMED 09/05/2008 18:00:43
-0.23% -0.10 sek, Vol: 598 860
Last: 42.70 sek
High: 43.60 sek Low: 42.70 sek
The Q-Med share
|
|
|
|
|
|
|